Fernando Valiente‐Echeverría

2.4k citations

54 papers · 1.3k indexed · h-index 24

Molecular Biology top 10%
Infectious Diseases top 5%
Virology top 2%
Immunology
Cardiology and Cardiovascular Medicine top 10%

Co-authors: Ricardo Soto‐Rifo Andrew J. Mouland Marcela A. Hermoso Marcelo López‐Lastra Valerie Le Sage Daniela Toro‐Ascuy Jorge Vera‐Otarola Aracelly Gaete-Argel
Topics: RNA Research and Splicing (19 papers)SARS-CoV-2 and COVID-19 Research (14 papers)RNA modifications and cancer (12 papers)
Cited by: Virology Infectious Diseases Parasitology
Journals: Nucleic Acids Research Nature CommunicationsSHILAP Revista de lepidopterología
Partner nations: Chile Canada United States

In The Last Decade

Fernando Valiente‐Echeverría

51 papers receiving 1.3k citations

Peers

Countries citing papers authored by Fernando Valiente‐Echeverría

Since Specialization

Citations

This map shows the geographic impact of Fernando Valiente‐Echeverría's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Valiente‐Echeverría with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Valiente‐Echeverría more than expected).

Fields of papers citing papers by Fernando Valiente‐Echeverría

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Valiente‐Echeverría. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Valiente‐Echeverría. The network helps show where Fernando Valiente‐Echeverría may publish in the future.

Co-authorship network of co-authors of Fernando Valiente‐Echeverría

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Valiente‐Echeverría. A scholar is included among the top collaborators of Fernando Valiente‐Echeverría based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Valiente‐Echeverría. Fernando Valiente‐Echeverría is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epidemiological surveillance and incidence of respiratory viruses in Chile: Before and after COVID 19 2025 ·Infectio ·(unknown),Alejandro A. Hidalgo,(unknown),Rafael I. González,(unknown),(unknown),Juan Castro‐Severyn,Coral Pardo-Esté,Ignacio Poblete‐Castro,Jorge Valdés,Fernando Valiente‐Echeverría,Gloria Arriagada,Aldo Gaggero,Francisco Remonsellez,Claudia P. Saavedra	0
2	Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner 2023 ·Frontiers in Immunology ·Cecilia Abreu,(unknown),(unknown),(unknown),Aracelly Gaete-Argel,Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo,(unknown),Alessandro Marcello,Sergio Pantano	1
3	Neutralizing antibodies from naturally infected individuals against SARS-CoV-2 Gamma and Delta variants in the Paraguayan population 2023 ·The Journal of Infection in Developing Countries ·Angélica Samudio,Pablo H. Sotelo,(unknown),(unknown),Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo,(unknown)	1
4	Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies 2022 ·BMC Medicine ·Leonardo Vargas,(unknown),Fabián Tempio,Valeska Simon,Daniela Sauma,(unknown),Caroll J. Beltrán,(unknown),(unknown),Mónica L. Acevedo,Johanna Acevedo,Rafael I. González,Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo,Mario Rosemblatt,Mercedes López,Fabiola Osorio,Marı́a Rosa Bono	10
5	Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile 2021 ·Science Advances ·(unknown),Sebastián Riquelme-Barrios,(unknown),Aracelly Gaete-Argel,(unknown),(unknown),Adam Aguirre,Dante Travisany,(unknown),Gonzalo P. Barriga,Aldo Gaggero,Constanza Martínez-Valdebenito,Nicole Le Corre,Marcela Ferrés,María Elvira Balcells,Jorge Onrubia Fernández,Eugenio Ramı́rez,Franz Villarroel‐Espíndola,Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo	20
6	Surveillance of seasonal respiratory viruses among Chilean patients during the COVID ‐19 pandemic 2021 ·Health Science Reports ·(unknown),C. Joaquín Cáceres,(unknown),(unknown),(unknown),Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo,Aldo Gaggero,Gonzalo P. Barriga	2
7	Call to Action: Supporting Latin American Early Career Researchers on the Quest for Sustainable Development in the Region 2021 ·SHILAP Revista de lepidopterología ·Sandra López‐Vergès,Fernando Valiente‐Echeverría,Álex Godoy‐Faúndez,David Fernández Rivas,Bernardo Urbani,(unknown),Paulina Carmona-Mora	8
8	CBP80/20-dependent translation initiation factor (CTIF) inhibits HIV-1 Gag synthesis by targeting the function of the viral protein Rev 2020 ·RNA Biology ·Francisco García-de-Gracia,Aracelly Gaete-Argel,Sebastián Riquelme-Barrios,(unknown),(unknown),(unknown),(unknown),(unknown),Mónica L. Acevedo,Jonás Chnaiderman,Fernando Valiente‐Echeverría,Daniela Toro‐Ascuy,Ricardo Soto‐Rifo	7
9	Strategies for Success. Viral Infections and Membraneless Organelles 2019 ·Frontiers in Cellular and Infection Microbiology ·Aracelly Gaete-Argel,Chantal L. Márquez,Gonzalo P. Barriga,Ricardo Soto‐Rifo,Fernando Valiente‐Echeverría	38
10	A Rev–CBP80–eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA 2018 ·Nucleic Acids Research ·Daniela Toro‐Ascuy,(unknown),Francisco García-de-Gracia,(unknown),(unknown),Aracelly Gaete-Argel,Fernando Valiente‐Echeverría,Théophile Ohlmann,Ricardo Soto‐Rifo	23
11	Emerging Roles of N6-Methyladenosine on HIV-1 RNA Metabolism and Viral Replication 2018 ·Frontiers in Microbiology ·Sebastián Riquelme-Barrios,(unknown),Fernando Valiente‐Echeverría,Ricardo Soto‐Rifo	25
12	HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases 2017 ·Scientific Reports ·Alessandro Cinti,Valerie Le Sage,Miroslav P. Milev,Fernando Valiente‐Echeverría,(unknown),(unknown),Nelly Panté,Martin Olivier,Andrew J. Mouland	30
13	Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation 2015 ·Virology Journal ·Valerie Le Sage,Alessandro Cinti,Fernando Valiente‐Echeverría,Andrew J. Mouland	36
14	Dual Mechanisms of Translation Initiation of the Full-Length HIV-1 mRNA Contribute to Gag Synthesis 2013 ·PLoS ONE ·Anne Monette,Fernando Valiente‐Echeverría,(unknown),Éric A. Cohen,Marcelo López‐Lastra,Andrew J. Mouland	41
15	A cis-Acting Element Present within the gag Open Reading Frame Negatively Impacts on the Activity of the HIV-1 IRES 2013 ·PLoS ONE ·Fernando Valiente‐Echeverría,(unknown),Anne Monette,Karla Pino,(unknown),J. Pablo Huidobro‐Toro,Andrew J. Mouland,Marcelo López‐Lastra	17
16	Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA 2013 ·RNA Biology ·Heather Gordon,Lara Ajamian,Fernando Valiente‐Echeverría,(unknown),William F. C. Rigby,Andrew J. Mouland	22
17	Identificación morfológica y molecular de filarías caninas en una comuna semi-rural de la Región Metropolitana, Chile 2012 ·Revista chilena de infectología ·Javier López,Fernando Valiente‐Echeverría,(unknown),Rubén Mercado,Katia Abarca	33
18	Bocavirus humano en Chile: características clínicas y epidemiológicas en niños con infecciones respiratorias 2011 ·Revista chilena de infectología ·(unknown),(unknown),(unknown),(unknown),(unknown),Fernando Valiente‐Echeverría,Cecilia Perret,(unknown),(unknown),(unknown)	7
19	The 5'-untranslated region of the mouse mammary tumor virus mRNA exhibits cap-independent translation initiation 2009 ·Nucleic Acids Research ·(unknown),(unknown),Fernando Valiente‐Echeverría,Kenneth Tapia,Felipe Rodríguez,Frederick H. Lowy,J. Pablo Huidobro‐Toro,John A. Dangerfield,Marcelo López‐Lastra	28
20	The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites 2009 ·Virology ·Andrea Rivas‐Aravena,(unknown),(unknown),Fernando Valiente‐Echeverría,Virginie Dormoy-Raclet,Felipe Rodríguez,Karla Pino,(unknown),J. Pablo Huidobro‐Toro,Imed‐Eddine Gallouzi,Marcelo López‐Lastra	56

About Fernando Valiente‐Echeverría

Fernando Valiente‐Echeverría is a scholar working on Virology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Research and Splicing (19 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Virology (271 citations), Infectious Diseases (447 citations) and Parasitology (95 citations). Fernando Valiente‐Echeverría has collaborated with scholars based in Chile, Canada and United States. Frequent co-authors include Ricardo Soto‐Rifo, Andrew J. Mouland, Marcela A. Hermoso, Marcelo López‐Lastra, Valerie Le Sage, Daniela Toro‐Ascuy, Jorge Vera‐Otarola, Aracelly Gaete-Argel, Katia Abarca and Javier López. Their work appears in journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact